PharmD Info

A forum for Indian Pharmacy Professionals

Its an open online forum for the Indian Doctors, Nurses and Pharmacists nurses, and allied health practitioners in all areas of medicine are invited to contact us with questions of a non-emergent nature.

Moderator: Doctors

  • User avatar
#2862
The first medicine designed to prevent migraines was approved by the Food and Drug Administration on Thursday, ushering in what many experts believe will be a new era in treatment for people who suffer the most severe form of these headaches.

The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. The list price will be $6,900 a year, and Amgen said the drug will be available to patients within a week.

References:

https://www.fda.gov/newsevents/newsroom ... 608120.htm

Tags

Journal selector tools will help you to find the b[…]

Pharmacy officer ,Sr pharmacy officer ,chief pharm[…]

The India specific drug safety signals/PI changes […]

Interview Q&A Clinical Trails - IQ OF CLINICAL[…]

WELCOME TO OUR E-LEARN COURSE WORK MODULES